Drawing for PHARMAVENTURES

USPTO serial 76228374

PHARMAVENTURES

Reviewed by CopyMark Law Group

Reg. 2774491Status 710
Filing date
Status date
Registration date
Oct 21, 2003
Examiner
OSLICK, SCOTT
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PHARMAVENTURES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laurence P. Colton

LAURENCE P COLTON SMITH RISLEY TEMPEL SANTOS LLCTwo Ravinia Drive, Suite 700Atlanta, GA 30346UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business information services for the pharmaceutical, healthcare research, medicated and non-medicated food and beverage and dietary supplements industries; market research services for concepts, products, supplements and preparations related to medication, dietetic products medicated and non-medicated additives for foodstuffs and beverages, and diagnostic products; and product licensing and transfer services for other of pharmaceutical drugs, medical devices, drug delivery devices, and diagnostics and platform technologies that accelerate drug discovery and developmentSECTION 8 - CANCELLED—
038Electronic transmission of data containing business information via a global computer networkSECTION 8 - CANCELLED—
039Electronic storage of data containing business informationSECTION 8 - CANCELLED—
042Intellectual property licensing and transfer services for others in the field of pharmaceutical drugs, medical devices, drug delivery devices, diagnostics and platform technologies that accelerate drug discovery and development; healthcare research and development of pharmaceuticals and dietary preparations, substances, and supplements performed for others; assisting others in obtaining clinical trial and research services in the fields of pharmaceuticals and biotechnology; providing information and database services in the fields of pharmaceuticals and biotechnology; providing information and database services in the fields of pharmaceuticals and biotechnology via databases provided on a global computer network, through intranets, and through subscriptions databases; providing consulting, design and development services to others for concepts, products, supplements and preparations related to medication, dietetic products, medicated and non medicated additives for foodstuffs and beverages, and diagnostic productsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 23, 2014CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Mar 26, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 15, 2009C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 18, 2009PLGLASSIGNED TO PARALEGAL—
Jun 16, 2009E815TEAS SECTION 8 & 15 RECEIVED—
Mar 17, 2008CFITCASE FILE IN TICRS—
Mar 4, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 21, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 29, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 9, 2003NPUBNOTICE OF PUBLICATION—
May 20, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 4, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 4, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 30, 2002DOCKASSIGNED TO EXAMINER—
Sep 23, 2002REINREINSTATED—
Apr 15, 2002PETRPETITION TO REVIVE-RECEIVED—
Apr 4, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 27, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance